Document resource
The idea that a prolonged interval between diagnosing and treating uveal melanoma can affect prognosis has been at the centre of an active debate.1–5 This issue focuses on a key question for aggressive cancers that spread early: Does treating the primary tumour per se improve survival, or is it merely palliative once micrometastases have formed?6 7